22Dec
Cadent Therapeutics Acquired by Novartis for Up to $770 Million
Cadent Therapeutics, a Cambridge, Massachusetts-based, privately held clinical stage biopharmaceutical company focused on the development of therapies for the treatment of cognitive, mood, and movement disorders, announced on December 17, 2020, that Novartis will acquire all of the outstanding capital stock of Cadent Therapeutics....
By:
Rothwell, Figg, Ernst & Manbeck, P.C.
Related
This summer I had the pleasure of traveling to Toronto and meeting Canadian construction lawyers to ...
Read More >
Last week, the California Supreme Court ruled that a former start-up employee could not hold his for...
Read More >
Subcontractors and contractors with pending construction contract claims, read your monthly applicat...
Read More >
A few months ago, Kamala Harris unveiled an ambitious plan to introduce stricter legal measures to f...
Read More >
Tryko Partners has announced it has acquired Glendale Uptown Home. Glendale Uptown Home, renamed Ro...
Read More >
On July 9, 2019, the New Jersey Supreme Court agreed to hear a case involving whether an employee ca...
Read More >